Der er blevet identificeret en hydroxyleret valdecoxibmetabolit i humant plasma (via CYP- vejen), som er aktiv som en COX- 2- hæmmer.
A hydroxylated metabolite of valdecoxib (via the CYP pathway) has been identified in human plasma that is active as a COX-2 inhibitor.